Phage based vaccine: A novel strategy in prevention and treatment
The vaccine was first developed in 1796 by a British physician, Edward Jenner, against the smallpox virus. This invention revolutionized medical science and saved lives around the world. The production of effective vaccines requires dominant immune epitopes to elicit a robust immune response. Thus,...
Main Authors: | Sharareh Mohammad Hasani, Elham Ghafouri, Shirin Kouhpayeh, Forouzan Amerizadeh, Ilnaz Rahimmanesh, Zohre Amirkhani, Hossein Khanahmad |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023071335 |
Similar Items
-
Novel SARS-COV2 poly epitope phage-based candidate vaccine and its immunogenicity
by: Sharareh Mohammad Hasani, et al.
Published: (2024-10-01) -
Aspects of Phage-Based Vaccines for Protein and Epitope Immunization
by: Marco Palma
Published: (2023-02-01) -
The enhancement of M13 phage titration by optimizing the origin of replication
by: Mohammad Hossein Darvishali, et al.
Published: (2024-07-01) -
Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections
by: Marco Palma, et al.
Published: (2024-11-01) -
Phages and phage therapy: past, present and future
by: Nour Essa, et al.
Published: (2020-06-01)